Management of patients with a history of GI bleeding who require anticoagulant treatment because of a high CHA2DS2-VASc score
How should we manage patients with a history of gastrointestinal bleeding who require anticoagulant treatment because of a high CHA2DS2-VASc score? Should we prefer novel oral anticoagulants in such patients?